An observational study in Neurodevelopmental Disorders, sponsored by University of Missouri-Columbia. Completed at 1 site in United States. Open to participants aged 4 Years to 15 Years. Per ClinicalTrials.gov, last updated 2022-03-28.
Sponsored by University of Missouri-Columbia · Observational
The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.
The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Research questions include: 1.) What are the perceptions of children and caregivers about intensive therapy after participating in multiple intensive therapy episodes over time? 2.) Why do caregivers choose to continue with an intensive model of therapy periodically for their child with neurodevelopmental diagnoses? 3.) What were the outcomes for children with neurodevelopmental disabilities participating in an episode of intensive therapy? Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.
332 studies on the registry are indexed under Neurodevelopmental Disorders; 143 are open to participants now.
This study's enrollment of 13 is below the median of 200 across 124 observational studies indexed under Neurodevelopmental Disorders.
Browse Neurodevelopmental Disorders studies →University of Missouri-Columbia is the lead sponsor of 357 studies on the registry; 70 are open to participants now.
Of its 42 completed or terminated interventional studies of FDA-regulated products, 28 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Children 4-15 years old with neurodevelopmental diagnoses and scheduled for an intensive therapy program over the summer.
Exclusion Criteria:
The intensive therapy program consists of physical therapy, occupational therapy, and speech therapy 3-6 hours x 4-5 days/week for 4 weeks. The individual therapies received will vary with the child/caregiver goals and be based on neuroplasticity and motor learning principles.
Semi-structured interviews
Upon completion of the program, children and caregivers will participate in an interview about their experience
Time frame: at discharge assessed up to 10 days
Canadian Occupational Performance Measure
Individualized client-centered performance measure
Time frame: measured at discharge 4 weeks after enrollment
Change in Lower extremity passive range of motion
Measured at ankle, knee, and hip with goniometer
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Thomas Test
Hip flexor length test
Time frame: Measured at day 1 and discharge 4 weeks later
Change in popliteal angle
Hamstring length test
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Gastrocnemius muscle length
Measured with goniometer
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Kids Bestest
Balance measure for pediatric patients
Time frame: Measured at day 1 and discharge 4 weeks later
Change in m-CTSIB
Balance measure
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Early Clinical Assessment of Balance
Balance measure
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Segmental Assessment of Trunk Control (SATCO)
Measurement of trunk control
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Edinburgh Visual Gait Scale
Observational Gait measure
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Timed Up and Down Stairs
Measure of stair performance
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Timed on and off the floor
Measure of transition from floor to standing
Time frame: Measured at day 1 and discharge 4 weeks later
Change in 6 minute walk test
Measure of walking performance
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Peds QL
Pediatric quality of life measure
Time frame: Measured at day 1 and discharge 4 weeks later
Change in GOAL
patient reported measure of function mobility
Time frame: Measured at day 1 and discharge 4 weeks later
Change in Pediatric Evaluation of Disability Inventory
Measure of amount of disability
Time frame: Measured at day 1 and discharge 4 weeks later
Pediatric Balance Scale
Measure of balance
Time frame: Measured at day 1 and discharge 4 weeks later
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Missouri-Columbia